How Will Investors Evaluate Your Medical Device Innovation?
Discover Your Funding Gaps in Less Than 5 Minutes
Investors don't simply invest in technology.
They invest in opportunities they understand.
The best technology doesn't always get funded.
The best prepared opportunity usually does.
If they can't clearly evaluate the clinical need, regulatory pathway, commercial potential, or development plan, even breakthrough innovations can struggle to secure funding.
The FRISK™ Investor Readiness Framework helps you see your innovation through an investor's eyes—before you ever enter the fundraising process.
Every Investor Is Trying to Answer One Question
Is This Opportunity Investable?
Before investors fund a medical device innovation, they evaluate five critical areas that determine whether an opportunity is investment ready—or still carries too much risk.
Why We Created FRISK™
Take the FRISK™ Investor Readiness Assessment
In less than five minutes you'll receive:
• Your Investor Readiness Score
• Your Biggest Funding Gaps
• A Five-Category Breakdown
• Potential Investor Concerns
• Personalized Recommendations
The FRISK™ Investor Readiness Framework measures those same five areas.
• Feasibility • Regulatory Strategy • Investor Readiness
• Solution Visualization • Key Market Validation
For decades, HaA Product Development has helped innovators transform promising concepts into commercially viable medical devices.
Across hundreds of development programs, one pattern became clear.
Innovative technologies often struggle to secure funding—not because the science isn't sound—but because investors cannot confidently evaluate the opportunity.
Founders frequently possess remarkable technology, yet lack the information, documentation, visual assets, development planning, and investor narrative needed to inspire confidence.
That's why we developed the FRISK™ Investor Readiness Framework.
To help innovators identify potential investor concerns, strengthen their opportunity, and become truly investor ready before fundraising begins.
What Investors Really Want to Know
Every investor is evaluating risk.
They're asking:
✓ Can this technology actually be developed?
✓ Is there a realistic regulatory pathway?
✓ Is there evidence customers will adopt it?
✓ Can I clearly understand the value proposition?
✓ Is this team prepared to execute?
If those questions can't be answered with confidence, funding becomes significantly more difficult—regardless of how innovative the technology may be.
Learn What It Takes to Become Investor Ready
After completing your assessment, you'll have the opportunity to schedule a complimentary FRISK™ Strategy Review.
During this session we'll:
✓ Review your Investor Readiness Score
✓ Explain how investors evaluate opportunities using the FRISK™ Framework
✓ Identify the biggest gaps reducing investor confidence
✓ Discuss practical ways to strengthen your opportunity
✓ Help determine whether a full FRISK™ Investor Readiness engagement is appropriate
You'll leave with greater clarity, a stronger understanding of the investor mindset, and a roadmap for moving your innovation toward investment readiness.
Ready to Discover Your Funding Gaps?
The best technology doesn't always get funded.
The best prepared opportunity usually does.
Take the complimentary FRISK™ Investor Readiness Assessment and discover how investors may evaluate your innovation before your next investor meeting.
✓ 5 Minutes
✓ No Cost
✓ Immediate Results
✓ Complimentary Strategy Review
Frequently Asked Questions:
What is the FRISK™ Investor Readiness Framework?
The FRISK™ Investor Readiness Framework is a structured methodology developed by HaA Product Development to help medical device innovators evaluate how prepared their innovation is for investor conversations. It assesses five critical areas investors use to evaluate risk: feasibility, regulatory strategy, investor readiness, solution visualization, and market validation.
What is the FRISK™ Investor Readiness Assessment?
The FRISK™ Assessment is a complimentary five-minute evaluation that scores your innovation across the five components of the FRISK Framework. It helps identify potential funding gaps, investor concerns, and practical next steps to strengthen your opportunity before fundraising.
Why do medical device startups struggle to raise investment?
Many medical device innovations fail to secure funding because investors cannot clearly evaluate the opportunity. Successful fundraising requires more than a great idea—it requires evidence of technical feasibility, regulatory planning, commercial potential, product visualization, and a compelling investment story.
What do medical device investors look for before investing?
Most investors evaluate opportunities using similar criteria, including:
Technical feasibility
Regulatory pathway
Clinical need
Market opportunity
Competitive differentiation
Product development strategy
Commercialization plan
Investment readiness
The FRISK Framework helps innovators evaluate these same factors before investor meetings.
What does investor readiness mean?
Investor readiness refers to how well a medical device company has prepared its technology, documentation, strategy, and business case for investment discussions. Investor-ready companies are able to clearly communicate risk, opportunity, development plans, and commercial potential.
How long does the FRISK Assessment take?
Most innovators complete the assessment in approximately five minutes.
Immediately afterward, you'll receive your Investor Readiness Score along with recommendations for strengthening your opportunity.
Is the FRISK Assessment free?
Yes.
The FRISK Investor Readiness Assessment is completely complimentary and designed to help innovators better understand how investors may evaluate their opportunity.
What happens after I complete the assessment?
You'll receive your Investor Readiness Score along with a breakdown across each FRISK category.
You'll also have the opportunity to schedule a complimentary strategy review with a HaA Product Development expert to discuss your results and next steps.
Who should take the FRISK Assessment?
The assessment is designed for:
Medical device startups
Physician innovators
Entrepreneurs
University spinouts
Early-stage medical technology companies
Founders preparing to raise capital
Companies preparing for strategic partnerships
What if my innovation is only an early concept?
That's exactly when the assessment provides the greatest value.
Identifying gaps early allows you to make better development decisions before investing significant time and capital.
Can the FRISK Framework help before I start fundraising?
Absolutely.
Many founders wait until they're actively raising money before identifying weaknesses in their opportunity. The FRISK Framework is designed to identify those issues early, allowing you to improve investor confidence before your first meeting.
What makes the FRISK Framework different?
Unlike generic startup scorecards, the FRISK Framework was developed specifically for medical device innovators.
It incorporates decades of product development experience and focuses on the unique technical, regulatory, clinical, and commercial considerations that influence medical device investment decisions.
Does the FRISK Framework replace a business plan or pitch deck?
No.
The FRISK Framework complements your business plan and pitch deck by helping ensure they address the questions investors are most likely to ask.
What is included in a FRISK Strategy Review?
During your complimentary strategy review, a HaA Product Development expert will:
Review your assessment results
Explain your Investor Readiness Score
Identify strengths and potential risks
Discuss investor expectations
Recommend practical next steps
Determine whether a full FRISK engagement would benefit your innovation
Can HaA help after the assessment?
Yes.
HaA Product Development provides end-to-end medical device product development services, including concept development, industrial design, engineering, regulatory planning, prototyping, investor-ready documentation, and commercialization support.
When should I take the FRISK Assessment?
The best time is before your next investor conversation.
Whether you're at the concept stage or preparing for a Series A raise, understanding your strengths and potential funding gaps can help improve investor confidence and make your fundraising efforts more effective.